Market research
FFC.AU FarmaForce Limited
AU AUD Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.37
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- ISIN
- AU000000FFC7
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- -0.37
About
About FarmaForce Limited
Farmaforce Limited provides contract sales services to the pharmaceutical industry in Australia. The company operates in two segments, Contract Sales and Marketing Services to External Customers; and Services to Related Parties. It also offers sales, data, and medical affairs solutions. The company was incorporated in 2014 and is based in Sydney, Australia. Farmaforce Limited is a subsidiary of The iQ Group Global Ltd.
Research context
FarmaForce Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the FFC.AU discussion.
5 years, 6 months ago
FarmaForce Limited is currently in a long term downtrend where the price is trading 19.7% below its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
FarmaForce Limited's total revenue sank by 6.9% to $6M since the same quarter in the previous year.
Its net income has increased by 124.8% to $577K since the same quarter in the previous year.
Finally, its free cash flow grew by 342.7% to $1M since the same quarter in the previous year.
Based on the above factors, FarmaForce Limited gets an overall score of 3/5.